The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors.
Abstract Details
Hepatocellular Carcinoma-How to Determine Therapeutic Options
Mehta N1. Hepatol Commun. 2020 Jan 22;4(3):342-354. doi: 10.1002/hep4.1481. eCollection 2020 Mar.
Author information
1 Division of Gastroenterology Department of Medicine University of California San Francisco San Francisco CA.
Abstract
Deciding on specific treatment strategies involves not only tumor stage, performance status, and severity of underlying liver disease, but additional factors such as biomarkers, organ availability, and radiographic tumor response to treatment. In this review, we present hepatocellular carcinoma (HCC) cases to highlight how to determine therapeutic options for HCC in specific scenarios, including resection versus liver transplant, choice of initial local regional treatment, tumor downstaging, and systemic therapies for advanced HCC.